Initiating chemotherapy in joint arthroplasty patients increases the risk of periprosthetic joint infections.
Amir Human HoveidaeiAmirhossein Ghaseminejad-RaeiniSeyed Hossein Hosseini-AslAshesh ShresthaArmin HoveidaeiSeyed Pouya TaghaviBasilia Onyinyechukwu NwankwoMohammad Saeid KhonjiJanet D ConwayPublished in: Archives of orthopaedic and trauma surgery (2024)
This study reveals a possible relationship between postoperative chemotherapy and an increased incidence of PJI in patients with arthroplasty. Chemotherapy suppresses the immune system, rendering patients more vulnerable to infections. Additional research is required to confirm these findings.